Current Ratio of Allogene Therapeutics, Inc. from 30 Jun 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Allogene Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2019 to 30 Sep 2025.
  • Allogene Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 882%, a 25% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Allogene Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 882% -290% -25% 30 Sep 2025
Q2 2025 911% -340% -27% 30 Jun 2025
Q1 2025 1002% -142% -12% 31 Mar 2025
Q4 2024 1071% +55% +5.4% 31 Dec 2024
Q3 2024 1172% +204% +21% 30 Sep 2024
Q2 2024 1250% +286% +30% 30 Jun 2024
Q1 2024 1144% +125% +12% 31 Mar 2024
Q4 2023 1016% -123% -11% 31 Dec 2023
Q3 2023 968% -177% -15% 30 Sep 2023
Q2 2023 965% -110% -10% 30 Jun 2023
Q1 2023 1019% -93% -8.4% 31 Mar 2023
Q4 2022 1139% +5.9% +0.52% 31 Dec 2022
Q3 2022 1144% +72% +6.7% 30 Sep 2022
Q2 2022 1074% -156% -13% 30 Jun 2022
Q1 2022 1112% -272% -20% 31 Mar 2022
Q4 2021 1133% -334% -23% 31 Dec 2021
Q3 2021 1072% -791% -42% 30 Sep 2021
Q2 2021 1230% -610% -33% 30 Jun 2021
Q1 2021 1384% -193% -12% 31 Mar 2021
Q4 2020 1467% -84% -5.4% 31 Dec 2020
Q3 2020 1864% +329% +21% 30 Sep 2020
Q2 2020 1840% +1170% +175% 30 Jun 2020
Q1 2020 1577% 31 Mar 2020
Q4 2019 1551% 31 Dec 2019
Q3 2019 1535% 30 Sep 2019
Q2 2019 670% 30 Jun 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.